SHSTC(SH:600620)2024-04-26 08:48Financial Performance - The company's operating revenue for Q1 2024 was CNY 3,978,948.18, representing a decrease of 93.97% compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of CNY 19,881,535.37, a decline of 365.71% year-over-year[5]. - The basic earnings per share for the period was -CNY 0.0290, down 366.06% from CNY 0.0109 in the previous year[10]. - The net loss for Q1 2024 was CNY 19,888,568.15, compared to a net profit of CNY 9,178,617.44 in Q1 2023, indicating a shift in performance[22]. - Comprehensive loss for Q1 2024 totaled CNY 108,659,523.41, compared to a loss of CNY 14,182,160.26 in Q1 2023[22]. - Basic and diluted earnings per share for Q1 2024 were both CNY -0.0290, compared to CNY 0.0109 in Q1 2023[23]. Cash Flow - The net cash flow from operating activities was -CNY 55,020,293.96, compared to -CNY 34,213,200 in the previous year, indicating a worsening cash flow situation[9]. - Cash inflow from operating activities in Q1 2024 was CNY 34,081,141.98, a decrease from CNY 123,658,713.62 in Q1 2023[25]. - Cash outflow for purchasing goods and services in Q1 2024 was CNY 46,482,321.48, compared to CNY 115,268,609.45 in Q1 2023[25]. - The total cash outflow from operating activities was $89,101,435.94, compared to $157,871,904.07 in the previous year, suggesting improved cost management[26]. - The company reported a net decrease in cash and cash equivalents of -$50,728,323.89, contrasting with an increase of $119,566,863.91 in the previous year, highlighting a challenging cash flow environment[26]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,956,297,858.27, a decrease of 5.07% from the previous year-end[6]. - The equity attributable to shareholders decreased by 6.95% to CNY 1,456,033,042.17 compared to the previous year-end[6]. - Total liabilities as of Q1 2024 were CNY 1,500,553,440.57, down from CNY 1,549,722,649.03 in the previous year[18]. - The company's current assets totaled RMB 1,853,591,900.83, down from RMB 1,895,380,810.80 at the end of 2023, indicating a decrease of about 2.77%[16]. - Non-current assets totaled RMB 1,102,705,957.44, down from RMB 1,218,827,832.92, reflecting a decrease of approximately 9.52%[17]. Inventory and Receivables - The company's inventory increased to RMB 1,373,040,948.46 from RMB 1,346,076,652.52, marking an increase of about 2.00%[16]. - The company’s receivables from accounts decreased to RMB 14,875,590.97 from RMB 25,226,945.66, indicating a significant decline of approximately 41.00%[16]. - The company’s other receivables increased to RMB 3,283,943.49 from RMB 2,713,903.93, marking an increase of about 21.00%[16]. Operating Costs - Total operating costs for Q1 2024 were CNY 30,681,901.83, down from CNY 60,820,573.44 in Q1 2023, representing a reduction of 49.5%[21]. - The company reported a significant increase in management expenses, which rose to CNY 21,163,033.38 in Q1 2024 from CNY 17,468,166.94 in Q1 2023[21]. Other Financial Metrics - The weighted average return on equity decreased to -1.28%, down 1.66 percentage points from 0.38% in the same period last year[10]. - Non-recurring gains and losses amounted to CNY 2,158,966.49 after tax, with significant contributions from government subsidies and asset disposals[8]. - The company did not achieve property sales in the Tianchen Health City 1A project, which significantly impacted revenue and profit[9]. - The company has a total of 17,493 common shareholders as of the end of the reporting period[12].